Ranitidine Hcl Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50mg/2ml
Reference Brands: Zantac (USA/EU), Rantac (India), Aciloc (india)
Category:
Gastrointestinal Drugs
Ranitidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid or to treat ulcers (sores in the lining of the stomach or intestine) that were not successfully treated with other medications.
Ranitidine HCl Injection is available in Injection
and strengths such as 50mg/2ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ranitidine HCl Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ranitidine HCl Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ranitidine is a histamine H2 receptor antagonist widely used to reduce the production of stomach acid. By blocking H2 receptors in the gastric lining, it effectively decreases acid secretion, helping to relieve symptoms associated with excess stomach acid. It has been commonly prescribed for the treatment of conditions such as peptic ulcer disease, gastroesophageal reflux disease (GERD), and Zollinger–Ellison syndrome.
Ranitidine can be administered through multiple routes, including oral tablets, syrups, and injectable forms such as intramuscular (IM) and intravenous (IV) injections. This flexibility makes it suitable for both outpatient and hospital settings, particularly when rapid acid suppression is required.
The medication works by providing relief from symptoms like heartburn, acid indigestion, and stomach discomfort, while also promoting healing of ulcers in the stomach and intestines. Due to its effectiveness and ease of use, ranitidine was widely utilized across global healthcare systems for many years as a reliable acid-reducing therapy.
However, its use has been significantly restricted or discontinued in many countries due to safety concerns related to impurities, and alternative medications are now more commonly recommended.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing